BioCentury | May 26, 2016
Financial News

Arrivo debuts with $49M

...to announce its first program soon. Butts was a co-founder and COO at anticonvulsive company Neuronex Inc....
BioCentury | May 5, 2014
Clinical News

Plumiaz diazepam nasal spray regulatory update

...or from previously approved products. Acorda gained the product through its December 2012 acquisition of Neuronex Inc....
BioCentury | May 3, 2014
Company News

Acorda slides on complete response for diazepam nasal spray

...or from previously approved products. Acorda gained rights to Plumiaz through its 2012 acquisition of Neuronex Inc....
BioCentury | Dec 16, 2013
Clinical News

Diazepam nasal spray regulatory update

...gained the proprietary formulation of diazepam as a nasal spray through its 2012 acquisition of Neuronex Inc....
BioCentury | Jul 15, 2013
Clinical News

Diazepam nasal spray: Phase II data

...literature or from previously approved products. Acorda gained the product through its 2012 acquisition of Neuronex Inc....
BioCentury | Apr 1, 2013
Clinical News

Diazepam nasal spray: Phase I data

...be included in the NDA submission. Acorda gained the product through its 2012 acquisition of Neuronex Inc....
BioCentury | Dec 24, 2012
Company News

Acorda Therapeutics, Inc., Neuronex deal

...Acorda completed its acquisition of Neuronex, which is developing a nasal spray formulation of diazepam for...
...a closing payment of $6.8 million. Acorda made an initial payment of $2 million to Neuronex...
...and an additional payment of $1.5 million to fund R&D activities prior to deal close. Neuronex...
BioCentury | Jul 14, 2012
Financial News

Aerial raises $3.8M

...January 2011 by the management team behind North Carolina-based neurology companies Addrenex Pharmaceuticals Inc. and Neuronex Inc....
...Khayrallah, and President and COO Stephen Butts, both of whom were executives at Addrenex and Neuronex...
...& Co. Ltd. (Tokyo:4507; Osaka:4507) acquired Addrenex, while Acorda Therapeutics Inc. (NASDAQ:ACOR) agreed to acquire Neuronex...
BioCentury | May 7, 2012
Company News

Hanmi Pharmaceutical, SK Biopharmaceuticals deal

...the product for acute repetitive seizures in China in 2013 and in Korea in 2015. Neuronex Inc....
BioCentury | Feb 20, 2012
Company News

Acorda, Neuronex deal

...Acorda agreed to acquire Neuronex, which is developing a nasal spray formulation of diazepam for epilepsy...
...spray formulation of diazepam for epilepsy. Acorda made an initial payment of $2 million to Neuronex...
...deal. Acorda has the option to complete the acquisition for an additional $6.8 million after Neuronex's...
Items per page:
1 - 10 of 13
BioCentury | May 26, 2016
Financial News

Arrivo debuts with $49M

...to announce its first program soon. Butts was a co-founder and COO at anticonvulsive company Neuronex Inc....
BioCentury | May 5, 2014
Clinical News

Plumiaz diazepam nasal spray regulatory update

...or from previously approved products. Acorda gained the product through its December 2012 acquisition of Neuronex Inc....
BioCentury | May 3, 2014
Company News

Acorda slides on complete response for diazepam nasal spray

...or from previously approved products. Acorda gained rights to Plumiaz through its 2012 acquisition of Neuronex Inc....
BioCentury | Dec 16, 2013
Clinical News

Diazepam nasal spray regulatory update

...gained the proprietary formulation of diazepam as a nasal spray through its 2012 acquisition of Neuronex Inc....
BioCentury | Jul 15, 2013
Clinical News

Diazepam nasal spray: Phase II data

...literature or from previously approved products. Acorda gained the product through its 2012 acquisition of Neuronex Inc....
BioCentury | Apr 1, 2013
Clinical News

Diazepam nasal spray: Phase I data

...be included in the NDA submission. Acorda gained the product through its 2012 acquisition of Neuronex Inc....
BioCentury | Dec 24, 2012
Company News

Acorda Therapeutics, Inc., Neuronex deal

...Acorda completed its acquisition of Neuronex, which is developing a nasal spray formulation of diazepam for...
...a closing payment of $6.8 million. Acorda made an initial payment of $2 million to Neuronex...
...and an additional payment of $1.5 million to fund R&D activities prior to deal close. Neuronex...
BioCentury | Jul 14, 2012
Financial News

Aerial raises $3.8M

...January 2011 by the management team behind North Carolina-based neurology companies Addrenex Pharmaceuticals Inc. and Neuronex Inc....
...Khayrallah, and President and COO Stephen Butts, both of whom were executives at Addrenex and Neuronex...
...& Co. Ltd. (Tokyo:4507; Osaka:4507) acquired Addrenex, while Acorda Therapeutics Inc. (NASDAQ:ACOR) agreed to acquire Neuronex...
BioCentury | May 7, 2012
Company News

Hanmi Pharmaceutical, SK Biopharmaceuticals deal

...the product for acute repetitive seizures in China in 2013 and in Korea in 2015. Neuronex Inc....
BioCentury | Feb 20, 2012
Company News

Acorda, Neuronex deal

...Acorda agreed to acquire Neuronex, which is developing a nasal spray formulation of diazepam for epilepsy...
...spray formulation of diazepam for epilepsy. Acorda made an initial payment of $2 million to Neuronex...
...deal. Acorda has the option to complete the acquisition for an additional $6.8 million after Neuronex's...
Items per page:
1 - 10 of 13